SCHEMBL1633845

SCHEMBL1633845

c1csc(-c2cc(OC3CCNCC3)c3nc(Nc4ccc(N5CCOCC5)cc4)ncc3c2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JUN P05412 1/20 0.50
MAPK8 P45983 1/20 0.50
MAPK10 P53779 1/20 0.50
SYK P43405 3/20 0.48
JAK2 O60674 7/20 0.47
TBK1 Q9UHD2 3/20 0.47
LRRK2 Q5S007 1/20 0.47
CDK4 P11802 6/20 0.46
CCND1 P24385 5/20 0.46
CDK2 P24941 5/20 0.46
CDK1 P06493 4/20 0.46
CCNB1 P14635 4/20 0.46
CCNE1 P24864 4/20 0.46
CYP1A1 P04798 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP1B1 Q16678 1/20 0.45
MYLK4 Q86YV6 1/20 0.45
STK17A Q9UEE5 1/20 0.45
JAK3 P52333 2/20 0.43
JAK1 P23458 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1632409 0.92 JUN (0.49) JUNMAPK8MAPK10SYKJAK2
SCHEMBL13362923 0.90 SYK (0.48) JUNMAPK8MAPK10SYKJAK2
SCHEMBL1632436 0.89 CDK4 (0.47) JUNMAPK8MAPK10JAK2TBK1
SCHEMBL1571308 0.87 SYK (0.46) JUNMAPK8MAPK10SYKJAK2
SCHEMBL13498238 0.85 LRRK2 (0.51) JUNMAPK8MAPK10SYKJAK2
SCHEMBL1633436 0.84 MAPK10 (0.50) JUNMAPK8MAPK10SYKJAK2
SCHEMBL13498239 0.83 CDK4 (0.51) SYKJAK2TBK1LRRK2CDK4
SCHEMBL13498240 0.83 CDK4 (0.53) SYKJAK2TBK1LRRK2CDK4
SCHEMBL12725100 0.83 CDK4 (0.52) SYKJAK2TBK1LRRK2CDK4
SCHEMBL1635198 0.82 TBK1 (0.56) SYKJAK2TBK1LRRK2CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed